SEARCH

SEARCH BY CITATION

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
AJMB_31019_sm_SupplFig1.tif2869KSupplemental Figure 1: Survival curves showing time to reach HDRS-21 score of 10 or less, stratified by genotype and drug treatment. Kaplan-Meier survival analysis log-rank p values are shown.
AJMB_31019_sm_SupplFig2.tif2870KSupplemental Figure 2: Survival curves showing time to reach a 50% reduction in HDRS-21, stratified by genotype and drug treatment. Kaplan-Meier survival analysis log-rank p values are shown.
AJMB_31019_sm_SupplFig3.tif2866KSupplemental Figure 3: Mean HDRS-21 scores at each assessment point, stratified by genotype and by drug treatment. Mixed-model analysis showed no significant genotype by time interactions.
AJMB_31019_sm_SupplTab1.doc33KSupplemental Table 1. Response rates by genotype after 3 weeks treatment. Response is defined as a 25% reduction in HDRS-21 score. Results are given as percent responder or non-responder across rows, with the number of genotype carriers shown in parentheses. The format of this table is modeled after that of Binder and coworkers (Binder et al., 2004)

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.